Author

C.T. Muijs

Observed names: C. Muijs, Christel T. Muijs

Institution: University Medical Center Groningen

Observed institution: University Medical Center Groningen

ORCID: 0009-0009-4009-6688

Observed ORCID: 0009-0009-4009-6688

OpenAlex ID: A5146884695

Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study

2026 · Robin B. den Boer, Stella Mook, et al. · Radiotherapy and Oncology · 1

The challenge of informed consent: Propensity score weighting to prevent selection bias

2026 · M.L. Frederiks, R.H.A. Verhoeven, et al. · Radiotherapy and Oncology

Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer

2026 · M.L. Frederiks, M.L. Frederiks, et al. · Radiotherapy and Oncology

The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer

2026 · M.L. Frederiks, M. Berbée, et al. · Clinical and Translational Radiation Oncology

OC-0508 Predicted reduction in ΔNTCP by model based selected proton therapy for oesophageal cancer patients

2022 · P. Klinker, E. Korevaar, et al. · Radiotherapy and Oncology

SP-0194 What is the impact of technique on the risk and severity of treatment-induced lymphopenia?

2022 · C. Muijs · Radiotherapy and Oncology

PO-1879 Trade-off in lung and heart dose and the impact on target robustness in VMAT of oesophageal cancer

2022 · S. Visser, M. Schol, et al. · Radiotherapy and Oncology

OC-0947 First clinical experiences in treating oesophageal cancer with intensity-modulated proton therapy

2022 · S. Visser, C.O. Ribeiro, et al. · Radiotherapy and Oncology

EP-1912: Robustness and organ sparing potential of intensity modulated proton therapy for lung cancer

2018 · H.P. Van der Laan, R.M. Anakotta, et al. · Radiotherapy and Oncology

Works count: 11

Citation count: 1

H-index: 1

I10-index: